Stock & Company Details
Enliven Therapeutics Inc $ELVN
Price:
N/A
N/A
73M
$4.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-34.69
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ELVN technical indicators
Latest Enliven Therapeutics Inc (ELVN) indicator readings as of 2026-08-28.
ELVN's 14-day RSI is 50.7, in neutral territory. At $57.86 it is trading 57.7% above its 200-day moving average of $36.69, and above its 50-day average of $54.52. Price sits near the lower Bollinger Band ($57.44 to $61.73). ADX reads 35.2, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.
Finance Bot
Ask your questions
Start by typing a question below.
